CD73 blockade could contribute to the delay in tumor growth in vivo independently of adaptive immune cells, innate immunity or NK cell-mediated ADCC, suggesting that CD73 might contribute to tumor metastasis via autocrine-like mechanisms outside of its ectonucleotidase activity. This evidence concerns the gene NT5E and neoplasm.